Episode 4 | Where Regulatory Meets Medical: The Key to De-Risking Drug Development
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Episode 4 | Where Regulatory Meets Medical: The Key to De-Risking Drug Development
-
Narrated by:
-
By:
About this listen
Christopher Floyd, Executive Medical Director, is joined by Roz Sutton, Regulatory Expert, to explore how regulatory and medical alignment plays a critical role in de-risking drug development. They discuss why regulatory strategy must be shaped early, how medical rationale strengthens regulatory decision-making, and what it takes to execute with confidence in an evolving landscape.
No reviews yet